Literature DB >> 8469632

Severe mitral insufficiency in mucopolysaccharidosis type III-B (Sanfilippo syndrome).

J Muenzer1, R H Beekman, L M Profera, E L Bove.   

Abstract

A 6-year-old girl with mucopolysaccharidosis (MPS) III-B (Sanfilippo syndrome) who developed severe mitral regurgitation and congestive heart failure requiring surgery (valvuloplasty) is reported. One year after surgery the patient remains well, with marked improvement in her physical activity, and without signs of heart failure. This is only the second report of severe mitral regurgitation in MPS III, and is the first report of a successful repair (valvuloplasty) of a dysplastic mitral valve in the MPS. Mitral valvuloplasty should be considered instead of valve replacement in any MPS patient with mitral valve regurgitation requiring surgery.

Entities:  

Mesh:

Year:  1993        PMID: 8469632     DOI: 10.1007/BF00796996

Source DB:  PubMed          Journal:  Pediatr Cardiol        ISSN: 0172-0643            Impact factor:   1.655


  3 in total

1.  Type 3 mucopolysaccharidosis: report of a case with severe mitral valve involvement.

Authors:  J K Herd; S Subramanian; H Robinson
Journal:  J Pediatr       Date:  1973-01       Impact factor: 4.406

Review 2.  Cardiovascular manifestations of heritable disorders of connective tissue.

Authors:  R E Pyeritz
Journal:  Prog Med Genet       Date:  1983

3.  Echocardiographic abnormalities in the mucopolysaccharide storage diseases.

Authors:  D M Gross; J C Williams; C Caprioli; B Dominguez; R R Howell
Journal:  Am J Cardiol       Date:  1988-01-01       Impact factor: 2.778

  3 in total
  6 in total

Review 1.  Genetics and metabolic cardiomyopathies.

Authors:  E C Wicks; P M Elliott
Journal:  Herz       Date:  2012-09       Impact factor: 1.443

Review 2.  Surgical Management of Valvular Heart Disease in Mucopolysaccharidoses: A Review of Literature.

Authors:  Barbara A Rosser; Calvin Chan; Andreas Hoschtitzky
Journal:  Biomedicines       Date:  2022-02-04

Review 3.  Cardiac disease in patients with mucopolysaccharidosis: presentation, diagnosis and management.

Authors:  Elizabeth A Braunlin; Paul R Harmatz; Maurizio Scarpa; Beatriz Furlanetto; Christoph Kampmann; James P Loehr; Katherine P Ponder; William C Roberts; Howard M Rosenfeld; Roberto Giugliani
Journal:  J Inherit Metab Dis       Date:  2011-07-09       Impact factor: 4.982

Review 4.  Cardiac characteristics and natural progression in Taiwanese patients with mucopolysaccharidosis III.

Authors:  Hsiang-Yu Lin; Ming-Ren Chen; Shan-Miao Lin; Chung-Lieh Hung; Dau-Ming Niu; Tung-Ming Chang; Chih-Kuang Chuang; Shuan-Pei Lin
Journal:  Orphanet J Rare Dis       Date:  2019-06-13       Impact factor: 4.123

Review 5.  Pre-operative Considerations in Adult Mucopolysaccharidosis Patients Planned for Cardiac Intervention.

Authors:  Benjamin Cross; Karolina M Stepien; Chaitanya Gadepalli; Ahmed Kharabish; Peter Woolfson; Govind Tol; Petra Jenkins
Journal:  Front Cardiovasc Med       Date:  2022-04-04

6.  EGFR activation triggers cellular hypertrophy and lysosomal disease in NAGLU-depleted cardiomyoblasts, mimicking the hallmarks of mucopolysaccharidosis IIIB.

Authors:  Valeria De Pasquale; Antonio Pezone; Patrizia Sarogni; Alfonso Tramontano; Gabriele Giacomo Schiattarella; Vittorio Enrico Avvedimento; Simona Paladino; Luigi Michele Pavone
Journal:  Cell Death Dis       Date:  2018-01-18       Impact factor: 8.469

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.